Although the role of CD19+CD24+CD38+ and CD19+CD24+CD27+ regulatory B cells have been investigated in patients with type 1 autoimmune pancreatitis (Sumimoto et al., 2014), the specific mechanism of action of CD19 is yet to be determined in pancreatic cancer. The gene discussed is CD19; the disease is pancreatic neoplasm.